ClinVar Miner

Submissions for variant NM_000038.6(APC):c.32dup (p.Gln12fs)

dbSNP: rs1561444620
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel RCV002534025 SCV003836620 uncertain significance Familial adenomatous polyposis 1 2023-02-18 reviewed by expert panel curation The c.32dup (p.Gln12Alafs*3) variant in APC is a duplication variant which inserts 1 nucleotide in the first coding exon of the APC gene, creating a frameshift and premature translation stop signal. Since the frameshift and the premature truncation codon occurs upstream of codon 49, PVS1 does not apply according to the APC-specific modifications of the PVS1 decision tree (PVS1 not met). The variant is not reported in gnomAD v2.1.1 (PM2_supporting). This variant has been observed in heterozygous state in 3 healthy unrelated adult individuals worth 1.5 healthy individual points in total (BS2_variable not met; Invitae and GeneDX internal data). In summary, this variant is a VUS for FAP based on the ACMG/AMP criteria applied, as specified by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel: PM2_Supporting (VCEP specifications version 1; date of approval 12/12/22).
Color Diagnostics, LLC DBA Color Health RCV000772573 SCV000905753 uncertain significance Hereditary cancer-predisposing syndrome 2023-11-07 criteria provided, single submitter clinical testing This variant inserts 1 nucleotide in exon 2 of the APC gene, creating a frameshift and premature translation stop signal. Alterations that cause premature truncation in the amino (N-) terminus of the APC protein have been associated with an attenuated phenotype and may have reduced penetrance and/or expressivity in comparison to classic familial adenomatous polyposis syndrome (FAP; PMID: 9585611, 11257105). To our knowledge, this variant has not been reported in individuals affected with APC-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of APC function is a known mechanism of disease (clinicalgenome.org). Although there is a suspicion that this variant may be associated with disease, additional functional and clinical studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance
Invitae RCV002534025 SCV000948869 pathogenic Familial adenomatous polyposis 1 2018-09-10 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in APC are known to be pathogenic (PMID: 17963004, 20685668). This variant has not been reported in the literature in individuals with APC-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln12Alafs*3) in the APC gene. It is expected to result in an absent or disrupted protein product.
Ambry Genetics RCV000772573 SCV004053851 uncertain significance Hereditary cancer-predisposing syndrome 2023-09-12 criteria provided, single submitter clinical testing The c.32dupA variant, located in coding exon 1 of the APC gene, results from a duplication of A at nucleotide position 32, causing a translational frameshift with a predicted alternate stop codon (p.Q12Afs*3). The predicted stop codon occurs in the 5’ end of theAPC gene. Premature termination codons in the 5’ end of a gene have been reported to escape nonsense-mediated mRNAdecay and/or lead to re-initiation (Rivas et al. Science. 2015 May 8;348(6235):666-9; Lindeboom et al. Nat Genet. 2016 Oct;48(10):1112-8; Rhee et al. Sci Rep. 2017 May 10;7(1):1653). The exact functional effect of this alteration is unknown. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
All of Us Research Program, National Institutes of Health RCV003999974 SCV004841685 uncertain significance Classic or attenuated familial adenomatous polyposis 2024-02-05 criteria provided, single submitter clinical testing This variant inserts 1 nucleotide in exon 2 of the APC gene, creating a frameshift and premature translation stop signal. Alterations that cause premature truncation in the amino (N-) terminus of the APC protein have been associated with an attenuated phenotype and may have reduced penetrance and/or expressivity in comparison to classic familial adenomatous polyposis syndrome (FAP; PMID: 9585611, 11257105). To our knowledge, this variant has not been reported in individuals affected with APC-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of APC function is a known mechanism of disease (clinicalgenome.org). Although there is a suspicion that this variant may be associated with disease, additional functional and clinical studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.